Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation
Johns Hopkins University · with The Hospital for Sick Children, Columbia University · NCT07778823
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 252
- US sites recruiting
- 7
- Study start
- June 29, 2025
- Record last updated
- August 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study evaluates whether an augmented reality cardiopulmonary resuscitation feedback system (AR-CPR) can support health care providers in delivering high-quality chest compressions during pediatric cardiac arrest. AR-CPR provides real-time visual feedback on chest compression rate, depth, and recoil through a head-mounted augmented reality display.
In this randomized, multicenter, international, simulation-based non-inferiority study, health care providers perform chest compressions during an 18-minute simulated pediatric cardiac arrest. Participants are assigned to receive either real-time feedback from AR-CPR or coaching from a trained human CPR coach. The primary objective is to determine whether the percentage of chest compressions meeting guideline targets for both rate and depth with AR-CPR is non-inferior to that achieved with human CPR coaching.
Being studied: AR-CPR
Conditions: Cardiac Arrest (CA); Pediatric Cardiac Arrest (Simulated); Cardiopulmonary Resuscitation (CPR)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Actively credentialed pediatric emergency department or pediatric intensive care unit nurse or clinical technician at a participating study site
- Current American Heart Association (AHA) Pediatric Advanced Life Support (PALS) certification
Exclusion Criteria
- Inability to physically perform chest compressions
- Need for prescription corrective lenses without having those corrective lenses available at the time of study participation
Recruiting US locations
All Childrens Hopsital
St. Petersburg, FL 33701
Site contact: Alyssa Rake, MD · 727-898-7451 · arake1@jh.edu
Johns Hopkins Children's Center
Baltimore, MD 21287
Site contact: Keith Kleinman, MD · 410-955-5000 · kkleinm3@jh.edu
Columbia University Vagelos College of Physicians and Surgeons
New York, NY 10032
Site contact: David Kessler, MD · 212-305-2862 · dk2592@cumc.columbia.edu
Childrens Hospital of Philadelphia
Philadelphia, PA 19104
Site contact: Brian Lee, MD · 215-590-1000 · leeb6@chop.edu
Brown/Hasbro Children's Hospital
Providence, RI 02903
Site contact: Frank Overly, MD · 401-444-4000 · frank.overly@brownphysicians.org
University of Texas Southwestern Medical center/ Children's Health of Dallas
Dallas, TX 75235
Site contact: Neethu Chandran, MD · 214-456-7000 · Neethu.Chandran@UTSouthwestern.edu
Texas Childrens
Houston, TX 77030
Site contact: Julie McCaw, MD · 832-824-1000 · jxmccaw@texaschildrens.org
Study contacts (from the official record)
- Keith Kleinman, MD · 410-955-5000 · kkleinm3@jh.edu
- Justin Jeffers, MD · 410-955-5000 · jjeffers@jhmi.edu
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65